Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Pre!
I should be called, "RENE_to_40_pounds"
I'm expecting one tomorrow morning or Friday morning
<
Maybe in Yen; I'm sure they're about £1.5B GBP
Egg - SanBio have that sort of MCAP so it's completely realistic for RENE
Relax, egg, good news is on its way :)
£3+ by end of next week or I'll eat my hat.
.... get your free money 'ere. No stopping till double-digit pounds. The longer you wait, the more you make.
Geeyeeeet your free money here luv, haaaaw much you want? Twenty bags of sand today, 80 bags in a months' time darlin. Rolllll up rolllll up.
This is going to surge tomorrow
I like the incentive conditions:
1) When the Company has signed out-licensing deal(s) for any of its technologies or programmes which, together with other financial resources, provides sufficient funding to allow the achievement of clinical proof of concept data for the CTX and hRPC programmes, one third of the options will vest.
2) When the Company's share price has doubled from the price at the date of grant, one third of the options will vest.
3) When the sixth clinical trial of a ReNeuron cell therapy completes, one third of the options will vest.
I wouldn't even flinch. It'll be short-lived and then it'll start to surge forward again. It will be £3+ very soon.
Those targets were set long before today's news liquid.
Expect them to be revised up considerably.
Likewise popes. And despite my name, I'm waiting for £40 not 40p! I chose that nickname before the 100-1 share consolidation!
youtu.be/7poiamvo_FQ
Hopefully with the RENE cells being able to be mass produced and then cryogenically frozen for transportation and storage prior to administration they will be able to offer the treatment at a much more reasonable price.
Whilst I'm obviously invested to make a decent profit, I don't want it to be at the expense of patients being ripped off.
Does anyone have an opinion as to whether something like this would be offered on the NHS in the UK or would it be private-only? I have no idea how that side of things works.
Not if the company are to be trusted. The management have repeatedly assured investors that they are looking for non-dilutive funding from here on in.
Wouldn't want to see him excited with a name like that
Apologies for off-topic post but just wanted to let Freddie know that there are a lot of well wishers on the RENE board hoping you're OK and wondering where u are!
Best wishes. JBJ
I chose the name "RENE_to_40p" about 5 years ago before the 100-1 share consolidation!
Where are you ol chap? I hope you're well.
Ha ha, yes well spotted Freddie
"p" now stands for "pounds"!
If the licensing deal for retinal treatment goes ahead in October (2018) and if PISCES phase III shows efficacy in placebo-controlled stroke study (results currently predicted for end of 2019) then they *will* be £40 a share. Keep the faith.
There will most likely be some sort of update on 12th September. They always release a company update RNS in the morning before the AGM. I don't expect anything before then.